drugset / Trial / NCT00544180
ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine the satisfaction of subject with Actonel 35 mg Once a Week in the treatment of post-menopausal osteoporosis. Open, non-controlled, multi-center study.
Timeline
- Start
- 2005-05
- Primary completion
- 2006-09
- Completion
- —
Outcome
Outcome not reported
Stopped: “The trial was terminated due to lack of compliance with GCP regulations.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risedronate | Small molecule | 35 mg | — |